Discovery of 1,4-Didydroxy-2-naphthoate Prenyltransferase Inhibitors:  New Drug Leads for Multidrug-Resistant Gram-Positive Pathogens

Journal of Medicinal Chemistry
2007.0

Abstract

Since utilization of menaquinone in the electron transport system is a characteristic of Gram-positive organisms, the 1,4-dihydroxy-2-naphthoate prenyltransferase (MenA) inhibitors 1a and 2a act as selective antibacterial agents against organisms such as methicillin-resistant Stapylococcus aureus (MRSA), Staphylococcus epidermidis (MRSE), and Mycobacterium spp. Growth of drug-resistant Gram-positive organisms was sensitive to the MenA inhibitors, indicating that menaquinone synthesis is a valid new drug target in Gram-positive organisms.

Knowledge Graph

Similar Paper

Discovery of 1,4-Didydroxy-2-naphthoate Prenyltransferase Inhibitors:  New Drug Leads for Multidrug-Resistant Gram-Positive Pathogens
Journal of Medicinal Chemistry 2007.0
Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis
Journal of Medicinal Chemistry 2012.0
Synthesis, optimization, in vitro and in vivo study of bicyclic substituted amine as MenA inhibitor
Bioorganic & Medicinal Chemistry Letters 2021.0
Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens
Journal of Medicinal Chemistry 2002.0
Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus
ACS Medicinal Chemistry Letters 2020.0
Biosynthesis of bacterial menaquinones. Menaquinone mutants of Escherichia coli
Biochemistry 1975.0
Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
Journal of Medicinal Chemistry 2016.0
Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections
European Journal of Medicinal Chemistry 2018.0
1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial Spectrum
ACS Medicinal Chemistry Letters 2022.0